Patents-Review.com
ClassID:

97089 ⎘

C07K14/8132 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors; Serine protease (E.C. 3.4.21) inhibitors; Serpins Plasminogen activator inhibitors

Recent Application in this class:
#1
20230173080
2023-06-08

COMPOSITION OF IMMUNOMODULATING SERPIN, SERP-1

 #2
20220372111
2022-11-24

POLYPEPTIDE INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY AND USES THEREOF

 #3
20220267751
2022-08-25

METHODS FOR MAKING RECOMBINANT PROTEIN

 #4
20210324047
2021-10-21

Antivirus proteins having a Kringle 5 subunit

 #5
20190151421
2019-05-23

METHOD FOR PREVENTING OR TREATING LIVER TISSUE DAMAGE AND ASSOCIATED DISEASES

 #6
20170008949
2017-01-12

Use of the binding domain of a subunit of a multi-subunit structure for targeted delivery of pharmaceutically active entities to the multi-subunit structure

 #7
20160318990
2016-11-03

Recombinant fibrinogen high-production line and method for producing same

 #8
20140315227
2014-10-23

Therapeutic agent for preterm delivery or abortion using plasminogen activator inhibitor-1

 #9
20130310305
2013-11-21

Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis

 #10
20130267022
2013-10-10

Polynucleotides encoding therapeutic inhibitors of PAI-1

 #11
20110055940
2011-03-03

Polynucleotides encoding therapeutic inhibitors of PAI-1

 #12
20100221254
2010-09-02

Methods and Compositions for PDGF-C Activation and Inhibition

 #13
20100215636
2010-08-26

Peptides derived from plasminogen activator inhibitor-1 and uses thereof

 #14
20100184667
2010-07-22

Modified plasminogen activator inhibitor type-1 molecule and methods based thereon

 #15
20100137209
2010-06-03

MODIFIED PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 AND METHODS BASED THEREON

 #16
20090208967
2009-08-20

Genetic Polymorphisms As Predictive Diagnostics For Adverse Drug Reactions (ADR) And Drug Efficacy

 #17
20090136421
2009-05-28

PAI-2 conjugates for the treatment and imaging of cancer

 #18
20090047284
2009-02-19

Methods and compositions for PDGF-C activation and inhibition

 #19
20070259806
2007-11-08

Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator

 #20
20060204962
2006-09-14

Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy

 #21
20060104978
2006-05-18

Methods and compositions for PDGF-C activation and inhibition

 #22
20060045878
2006-03-02

Pancreas-derived plasminogen activator inhibitor

 #23
20050158295
2005-07-21

Modified plasminogen activator inhibitor type-1 and methods based thereon

 #24
20050148527
2005-07-07

DNA enzyme to inhibit plasminogen activator inhibitor-1